Open House Contract for Peginterferon beta 1a
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 20 - Peginterferon beta 1a
Opportunity Score
Why this score?
Opportunity
56 / 100
Complexity
68 / 100
Risk factors
Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...
Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jul 2028
- Conclude non-exclusive discount agreements for Peginterferon beta 1a under § 130a Abs. 8 SGB V.
- Provide pharmaceutical products for nationwide performance in Germany.
Show full summary
This is a German Open House supply arrangement by Techniker Krankenkasse for the active substance Peginterferon beta 1a (CPV 33600000 Pharmaceutical products). It is not an exclusive award procedure: all pharmaceutical undertakings meeting the stated conditions may enter into the contract on uniform terms. The contract term is up to 24 months from 01.08.2026 and ends no later than 31.07.2028, with earlier automatic termination if patent/market exclusivity ends. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. No contract value is stated.
Risks
Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...
Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the offered medicine(s).
- Applicant must have its registered seat in the scope of the AMG, another EU Member State, or another EEA state.
- Applicant must have a valid authorisation for the contract medicine or otherwise be entitled to market it in its own name.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Contract for Peginterferon beta 1a
Open House supply arrangement for Peginterferon beta 1a. The notice indicates nationwide performance in Germany. Contract terms are uniform and non-exclusive; no individual negotiations are conducted. The lot information is taken from structured data and XML notice.
Location
Duration
Category
Award Criteria
Deadline
Award details
Award criteria are not meaningful for this Open House procedure
the notice states the selected criterion type is irrelevant and only included to satisfy form requirements.
Value note
Show original TED data
Original lot title
Open House Biologika Rabattverträge 2026 - 20 - Peginterferon beta 1a
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Peginterferon beta 1a zu schließen.
Procurement Details
- Publication date
- 31 May 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 372206-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
56 / 100
Complexity
68 / 100
Risk factors
Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...
Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications